These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4766061)

  • 41. [Enzyme diagnosis of liver diseases].
    Weber H
    Hippokrates; 1969 Dec; 40(23):904-7. PubMed ID: 5396918
    [No Abstract]   [Full Text] [Related]  

  • 42. [Chronic hepatitis: characteristics of clinical symptoms].
    Hirayama C; Tada H; Fukuda T; Hirose S; Kawabe M
    Saishin Igaku; 1966 Aug; 21(8):1789-99. PubMed ID: 5975040
    [No Abstract]   [Full Text] [Related]  

  • 43. [Chromodiagnostics of the liver using bromsulfan and ujoviridin. 1. Methods and normal values of bromsulfan- and ujoviridin test, studies in inflammatory liver diseases and fatty liver].
    Seidel R; Hölzel W; Reissmann G
    Z Gesamte Inn Med; 1971 Jul; 26(13):435-41. PubMed ID: 5125153
    [No Abstract]   [Full Text] [Related]  

  • 44. [Study of hepatic parenchymatous function. Contribution of the galactose clearance test. Study by multidimensional statistical analysis].
    Hecht Y; Ben Amar A; Touboul JP; el-Guedry H; Salmon D; Nakache JP
    Nouv Presse Med; 1972 Dec; 1(46):3133-4. PubMed ID: 4650517
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparison of the value of the glucagon test and galactose tolerance test in the clinical diagnosis of cirrhosis].
    Poniewierka E
    Wiad Lek; 1990 Feb 1-15; 43(3-4):107-13. PubMed ID: 2368389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Results of SGPT screenings in 9 district blood-donor institutes with consecutive clinical examination of conspicuous blood donors].
    Jorke D; Scheffler W; Wagner M; Reinhardt M; Peschel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(3):354-67. PubMed ID: 4123100
    [No Abstract]   [Full Text] [Related]  

  • 47. [Examination of intravenous galactose loading test. 2].
    Fukui I; Soyama H; Ono E; Yoshida T; Takino TT
    Rinsho Byori; 1971 Aug; 19():Suppl:390. PubMed ID: 5168078
    [No Abstract]   [Full Text] [Related]  

  • 48. [Oral galactose tolerance test for liver function control. Dosage and standards].
    Avenarius HJ; Gutjahr L
    Med Klin; 1971 Dec; 66(50):1734-8. PubMed ID: 5159631
    [No Abstract]   [Full Text] [Related]  

  • 49. [Diagnostic value of tests for estimation of disease activity in patients with chronic hepatitis and liver cirrhosis].
    Kurdybaĭlo FV; Iakhontova OI; Orlova IN
    Vrach Delo; 1976 Dec; (12):68-71. PubMed ID: 1014592
    [No Abstract]   [Full Text] [Related]  

  • 50. [Parenchymatous liver functional examination. Contribution of the intravenous galactose clearance test. Study with multidimensional statistical analyses].
    Hecht Y; Benamar A; Touboul JP; el-Guedri H; Nakache JP; Salmon D
    Med Chir Dig; 1973; 2(2):81-90. PubMed ID: 4743211
    [No Abstract]   [Full Text] [Related]  

  • 51. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
    Holtmeier J; Leuschner M; Schneider A; Leuschner U; Caspary WF; Braden B
    Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The bromsulphalein and galactose tolerance tests in patients with various liver diseases. A comparative study.
    den Blaauwen DH; Thijs LG
    Acta Gastroenterol Belg; 1973; 36(7):345-75. PubMed ID: 4751674
    [No Abstract]   [Full Text] [Related]  

  • 53. [Non-alcoholic steato-hepatitis].
    Linhart HG
    Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Nonalcoholic steatohepatitis].
    da Silva PM; Eliseu T; Costa MM; Bastos H; Nobre FL
    Acta Med Port; 1995 May; 8(5):323-7. PubMed ID: 7625233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis.
    Lindskov J
    Acta Med Scand; 1982; 212(5):295-302. PubMed ID: 7180579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of an intravenous galactose tolerance test].
    Fukui I; Soyama K; Ono E; Yoshida T; Takino T
    Rinsho Byori; 1971 Jan; 19(1):14-8. PubMed ID: 5103825
    [No Abstract]   [Full Text] [Related]  

  • 57. [Diagnostic validity of the intravenous galactose tolerance test in liver cirrhosis (author's transl)].
    Böhmer R; Rommel K
    Acta Hepatogastroenterol (Stuttg); 1972; 19(5):344-56. PubMed ID: 4668529
    [No Abstract]   [Full Text] [Related]  

  • 58. [Diversity of the chronic aggressive hepatitides].
    Martin E; Krähenbühl B
    Schweiz Med Wochenschr; 1970 Oct; 100(41):1709-18. PubMed ID: 5480539
    [No Abstract]   [Full Text] [Related]  

  • 59. [Factor analysis of the diagnosis of chronic hepatopathies. Possible new expressions of liver function?].
    Testa R; Agnese G; Dellepiane F; Rovida S; Risso D; Celle G
    Recenti Prog Med; 1982 Jan; 72(1):118-25. PubMed ID: 7079552
    [No Abstract]   [Full Text] [Related]  

  • 60. Gastrointestinal disorders in chronic alcoholics.
    Dinoso VP; Chey WY; Padow D; Rosen A; Ottenberg D; Lorber SH
    Am J Gastroenterol; 1971 Sep; 56(3):209-15. PubMed ID: 5121543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.